Aprea Therapeutics (APRE) Earnings Date & Reports

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

APRE is expected to report earnings to fall 14.77% to -18 cents per share on August 06

Aprea Therapeutics APRE Stock Earnings Reports

Q2'26

Est.

$-0.19

Q1'26

Missed

by $0.10

Q4'25

Missed

by $0.01

Q3'25

Missed

by $0.19

Q2'25

Missed

by $0.27

The last earnings report on May 13 showed earnings per share of -21 cents, missing the estimate of -11 cents. With 61.97K shares outstanding, the current market capitalization sits at 8.65M.

View a ticker or compare two or three

Compare

APRE

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for APRE